Skip to main content

#161922

SK-N-BE(2)-C Cell Line

Cat. #161922

SK-N-BE(2)-C Cell Line

Cat. #: 161922

Availability: 8-10 weeks

Organism: Human

Tissue: Brain

Model: Tumourigenic

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: June L. Biedler, Barbara A. Spengler

Institute: Memorial Sloan-Kettering Cancer Center (MSK)

Primary Citation: Ciccarone et al. 1989. Cancer Research. 49: 219-225. PMID: 2535691.

Tool Details
Applications
Handling
Related Tools
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: SK-N-BE(2)-C Cell Line
  • Cancer: Neurological cancer
  • Cancers detailed: Neuroblastoma
  • Parental cell: SK-N-BE(2)
  • Organism: Human
  • Gender: Male
  • Tissue: Brain
  • Donor: This cell line is a subclone of the SK-N-BE(2) neuroblastoma cell line. The parental cell line was established in 1972 from a metastatic site (bone marrow) in a two-year-old Caucasian male with malignant neuroblastoma.
  • Morphology: Neuroblast
  • Growth properties: Adherent
  • Model: Tumourigenic
  • Description: SK-N-BE(2)-C is a clonal subline of the SK-N-BE(2) neuroblastoma cell line. Like the parental cell line, these cells display MYCN amplification. Treatment with trans-retinoic acid differentiates these cells into a distinct neuronal phenotype. These cells display high levels of tyrosine hydroxylase activity and dopamine-b-hydroxylase activity.
  • Application: 3D cell culture; Immunology; Neuroscience
  • Biosafety level: 1
  • Additional notes: BE(2)-C cells have a reported saturation density of greater than 5 X 105 cells/cm2. The cells grow as clusters of flattened neuroblastic cells with occasional fine cell processes (neurites). Unlike the parent line, they generally do not detach and float.

Applications

  • Application: 3D cell culture; Immunology; Neuroscience

Handling

  • Growth medium: 1:1 mixture of EMEM:F12 Medium, then supplemented with FBS to a final concentration of 10%
  • Temperature: 37° C
  • Atmosphere: 5% CO2 in air
  • Shipping conditions: Dry Ice
  • Storage medium: Complete growth medium supplemented with 5% (v/v) DMSO
  • Storage conditions: Vapor phase of liquid nitrogen
  • Str profiling: Amelogenin: XCSF1PO: 10D13S317: 11D16S539: 9,11D5S818: 12D7S820: 9,10TH01: 6TPOX: 11vWA: 18D3S1358: 19D21S11: 30,32.2D18S51: 16Penta_E: 14,18Penta_D: 13,14D8S1179: 13,14FGA: 22,25D19S433: 12,13D2S1338: 23

Related Tools

  • Related tools: SK-N-BE(2)

References

  • Qiao et al. 2012. Biochemical and Biophysical Research Communications. 424: 421-426. PMID: 22766505.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.